FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3009043885> ?p ?o ?g. }

• W3009043885 endingPage "954" @default.
• W3009043885 startingPage "951" @default.
• W3009043885 abstract "Four formulations of an investigational tetravalent dengue purified inactivated vaccine, administered as two doses one month (M) apart, were previously shown to be immunogenic and well-tolerated up to M13 of the phase I study NCT01702857. Here, we report results of the follow-up from M14 to year (Y) 3. One hundred healthy Puerto Rican adults, predominantly dengue virus (DENV)–primed, were randomized 1:1:1:1:1 to receive placebo or vaccine formulations: 1 μg/serotype/dose adjuvanted with aluminum, AS01 E or AS03 B , or aluminum-adjuvanted 4 μg/serotype/dose. No serious adverse events occurred. Two medically-attended potential immune-mediated disease cases, vaccination unrelated, were reported (groups 1 µg+Alum and 1 µg+AS03 B ). Of 14 instances of suspected dengue, none were laboratory confirmed. Geometric mean neutralizing antibody titers against DENV 1-4 waned from M14, but remained above pre-vaccination levels for DENV 1-3, with the highest values for group 1 µg+AS03 B : 1220.1, 920.5, 819.4, and 940.5 (Y2), and 1329.3, 1169.2, 1219.8, and 718.9 (Y3). All formulations appeared to be safe and immunogenic during the 3-year follow-up." @default.
• W3009043885 created "2020-03-13" @default.
• W3009043885 creator A5003994833 @default.
• W3009043885 creator A5007520094 @default.
• W3009043885 creator A5008667687 @default.
• W3009043885 creator A5012552931 @default.
• W3009043885 creator A5022694965 @default.
• W3009043885 creator A5032224704 @default.
• W3009043885 creator A5041792637 @default.
• W3009043885 creator A5059606373 @default.
• W3009043885 creator A5069893446 @default.
• W3009043885 creator A5076243921 @default.
• W3009043885 creator A5077522136 @default.
• W3009043885 creator A5079356809 @default.
• W3009043885 creator A5079778326 @default.
• W3009043885 creator A5086456758 @default.
• W3009043885 creator A5087874713 @default.
• W3009043885 date "2020-05-06" @default.
• W3009043885 modified "2023-10-16" @default.
• W3009043885 title "Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study" @default.
• W3009043885 cites W1967739298 @default.
• W3009043885 cites W2107502676 @default.
• W3009043885 cites W2129640543 @default.
• W3009043885 cites W2470330280 @default.
• W3009043885 cites W2587810267 @default.
• W3009043885 cites W2600895116 @default.
• W3009043885 cites W2769142594 @default.
• W3009043885 cites W2790980096 @default.
• W3009043885 cites W2802296577 @default.
• W3009043885 cites W2807989886 @default.
• W3009043885 cites W2954833653 @default.
• W3009043885 doi "https://doi.org/10.4269/ajtmh.19-0461" @default.
• W3009043885 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7204593" @default.
• W3009043885 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32124728" @default.
• W3009043885 hasPublicationYear "2020" @default.
• W3009043885 type Work @default.
• W3009043885 sameAs 3009043885 @default.
• W3009043885 citedByCount "9" @default.
• W3009043885 countsByYear W30090438852020 @default.
• W3009043885 countsByYear W30090438852021 @default.
• W3009043885 countsByYear W30090438852022 @default.
• W3009043885 countsByYear W30090438852023 @default.
• W3009043885 crossrefType "journal-article" @default.
• W3009043885 hasAuthorship W3009043885A5003994833 @default.
• W3009043885 hasAuthorship W3009043885A5007520094 @default.
• W3009043885 hasAuthorship W3009043885A5008667687 @default.
• W3009043885 hasAuthorship W3009043885A5012552931 @default.
• W3009043885 hasAuthorship W3009043885A5022694965 @default.
• W3009043885 hasAuthorship W3009043885A5032224704 @default.
• W3009043885 hasAuthorship W3009043885A5041792637 @default.
• W3009043885 hasAuthorship W3009043885A5059606373 @default.
• W3009043885 hasAuthorship W3009043885A5069893446 @default.
• W3009043885 hasAuthorship W3009043885A5076243921 @default.
• W3009043885 hasAuthorship W3009043885A5077522136 @default.
• W3009043885 hasAuthorship W3009043885A5079356809 @default.
• W3009043885 hasAuthorship W3009043885A5079778326 @default.
• W3009043885 hasAuthorship W3009043885A5086456758 @default.
• W3009043885 hasAuthorship W3009043885A5087874713 @default.
• W3009043885 hasBestOaLocation W30090438851 @default.
• W3009043885 hasConcept C10389963 @default.
• W3009043885 hasConcept C126322002 @default.
• W3009043885 hasConcept C142724271 @default.
• W3009043885 hasConcept C159047783 @default.
• W3009043885 hasConcept C159654299 @default.
• W3009043885 hasConcept C168563851 @default.
• W3009043885 hasConcept C197934379 @default.
• W3009043885 hasConcept C203014093 @default.
• W3009043885 hasConcept C204787440 @default.
• W3009043885 hasConcept C22070199 @default.
• W3009043885 hasConcept C27081682 @default.
• W3009043885 hasConcept C2776872762 @default.
• W3009043885 hasConcept C2779261636 @default.
• W3009043885 hasConcept C2779308166 @default.
• W3009043885 hasConcept C2779635636 @default.
• W3009043885 hasConcept C2780868878 @default.
• W3009043885 hasConcept C32611913 @default.
• W3009043885 hasConcept C533803919 @default.
• W3009043885 hasConcept C71924100 @default.
• W3009043885 hasConceptScore W3009043885C10389963 @default.
• W3009043885 hasConceptScore W3009043885C126322002 @default.
• W3009043885 hasConceptScore W3009043885C142724271 @default.
• W3009043885 hasConceptScore W3009043885C159047783 @default.
• W3009043885 hasConceptScore W3009043885C159654299 @default.
• W3009043885 hasConceptScore W3009043885C168563851 @default.
• W3009043885 hasConceptScore W3009043885C197934379 @default.
• W3009043885 hasConceptScore W3009043885C203014093 @default.
• W3009043885 hasConceptScore W3009043885C204787440 @default.
• W3009043885 hasConceptScore W3009043885C22070199 @default.
• W3009043885 hasConceptScore W3009043885C27081682 @default.
• W3009043885 hasConceptScore W3009043885C2776872762 @default.
• W3009043885 hasConceptScore W3009043885C2779261636 @default.
• W3009043885 hasConceptScore W3009043885C2779308166 @default.
• W3009043885 hasConceptScore W3009043885C2779635636 @default.
• W3009043885 hasConceptScore W3009043885C2780868878 @default.
• W3009043885 hasConceptScore W3009043885C32611913 @default.
• W3009043885 hasConceptScore W3009043885C533803919 @default.
• W3009043885 hasConceptScore W3009043885C71924100 @default.
• W3009043885 hasIssue "5" @default.

• next